Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29711
Title: | , Safety, Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With colchicine-resistant FMF: Results From the Phase 3 CLUSTER Trial | Authors: | özen, S Koné-Paut, I Hofer, M VAN DER HILST, Jeroen Gül, Ahmet Brogan, Paul Manna, Rafaelle |
Issue Date: | 2017 | Source: | 24th Pediatric Rheumatology Congress, Athens, Greece, 14/09/2017 | Document URI: | http://hdl.handle.net/1942/29711 | DOI: | 10.1186/s12969-017-0186-9 | Category: | C2 | Type: | Conference Material |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
published abstract canakinumab pediatric rheumatology.pdf | Conference material | 1.55 MB | Adobe PDF | View/Open |
Page view(s)
52
checked on Sep 6, 2022
Download(s)
164
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.